Drugs / TECHNETIUM MEBROFENIN

Regulatory milestones approvals, filings & regulatory actions · 1 recorded

MilestoneJurisdictionBrandIndicationDateSentence it was read from
Approved US (FDA) TECHNETIUM TC-99M MEBROFENIN — 2008-01-29 fda.gov ↗

Trials 1

today
US approved 2008
NCT02235233 · Ph 1
20082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT02235233 Apr 2015 → Jul 2016 metabolic dysfunction-associated steatohepatitis University of North Carolina, Chapel Hill Completed No outcome recorded

Evidence & citations 7 cited values

Every value below carries the sentence it was read from. 3 sources stand behind the page.

FieldValueCited text
Known as TECHNETIUM MEBROFENIN ChEMBL registry synonym — accepted as the source's own label CHEMBL2110555 ↗
Known as 99mtc-mebrofenin ChEMBL registry synonym — accepted as the source's own label CHEMBL2110555 ↗
Known as Choletec ChEMBL registry synonym — accepted as the source's own label CHEMBL2110555 ↗
Known as Technetium (99m tc) mebrofenin ChEMBL registry synonym — accepted as the source's own label CHEMBL2110555 ↗
Known as Technetium Tc 99M Mebrofenin ClinicalTrials.gov intervention name — accepted as the source's own label NCT02235233 ↗
Known as Technetium tc-99m mebrofenin kit ChEMBL registry synonym — accepted as the source's own label CHEMBL2110555 ↗
Modality Diagnostic / imaging agent “the hepatobiliary imaging agent (99m)Technetium-mebrofenin” PMID 23887590 ↗ Jan 2013